Finance
Novo Nordisk Pill Drives 500K Prescriptions, Battles Eli Lilly
Novo Nordisk's new oral weight loss pill, Wegovy, has seen a strong launch with over 500,000 prescriptions written in its first month. The drug aims to overcome patient reluctance towards injections, though side effects like nausea are present. The company faces stiff competition from Eli Lilly, which recently launched its own rival pill with fewer restrictions.